Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.3 (
phospholipase C
)
18,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Membrane components, such as phospholipids, play an important role in the regulation of prostatic
5alpha-reductase
activity. To describe in more detail the impact of such regulation on
5alpha-reductase
activity, epithelial and stromal cell homogenates of human BPH were treated with phospholipases to specifically alter the structure of cellular phospholipid components. Phospholipase A(2) (PLA(2)) was used to alter the structure of the nonpolar, hydrophobic region of the membrane bilayer. Various types of
phospholipase C
(
PLC
) affect the polar, hydrophilic region of phospholipids. In epithelium and stroma,
5alpha-reductase
activity was dose-dependently inhibited by PLA(2) and
PLC
type III. In epithelium and stroma, the mean IC(50) values of PLA(2) were 9.4 +/- 1.1 and 13.9 +/- 2.6 [U/mg protein +/- SEM], respectively. The mean IC(50) values of
PLC
type III in epithelium and stroma were 4.5 +/- 1.2 and 1.7 +/- 0.2 [U/mg protein +/- SEM], respectively. In epithelium as well as in stroma,
5alpha-reductase
activity was more greatly inhibited by
PLC
type III than by PLA(2). Both in epithelium and stroma, PLA(2) significantly decreased the V(max) of
5alpha-reductase
whereas its K(m) remained unaffected. A similar decrease in V(max) was found with
PLC
type III in epithelium and stroma. Furthermore, the K(m) of epithelial
5alpha-reductase
increased significantly following the addition of
PLC
type III. The two phospholipases, with their specific substrate affinities and sites of hydrolysis, exhibited significantly different effects on
5alpha-reductase
, indicating that
5alpha-reductase
activity is not unspecifically affected by modification of the hydrophilic milieu. Rather,
5alpha-reductase
activity is specifically modulated by various phospholipids and/or phospholipolysis mediated degradation products. These findings suggest that the structural composition of the lipid environment plays a fundamental role in the post-translational regulation of
5alpha-reductase
activity in the epithelium and stroma of human BPH. Thus, changes in membrane phospholipid content seem to be instrumental in the expression of DHT-dependent processes.
...
PMID:In vitro modulation of steroid 5alpha-reductase activity by phospholipases in epithelium and stroma of human benign prostatic hyperplasia. 1118 41